Company Filing History:
Years Active: 2007
Title: Febrice Vergne: Innovator in Phosphodiesterase-7 Inhibitors
Introduction
Febrice Vergne is a notable inventor based in Chevry, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphodiesterase-7 inhibitors. His work has the potential to impact the treatment of various disorders.
Latest Patents
Febrice Vergne holds a patent for "Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors." This invention provides compounds that act as PDE7 inhibitors, characterized by specific formulas. The patent outlines methods for preparing these compounds and their therapeutic applications for disorders relevant to PDE7 inhibition. He has 1 patent to his name.
Career Highlights
Vergne is associated with Warner-Lambert Company, where he has been involved in innovative research and development. His expertise in medicinal chemistry has contributed to advancements in pharmaceutical formulations and therapeutic strategies.
Collaborations
Throughout his career, Febrice Vergne has collaborated with notable colleagues, including Patrick Bernardelli and Pierre Ducrot. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Febrice Vergne's work in developing phosphodiesterase-7 inhibitors showcases his commitment to advancing medical science. His contributions are significant in the realm of pharmaceuticals, and his patent reflects his innovative spirit.